India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country. Pfizer sought a patent that covers an important chemical formulation of the active compound…
Lesen Sie weiter
Latest in Drugmaker Archives - Access International Patent
Weitere Beiträge
(Reuters) – Drugmaker Mylan N.V said it settled a patent litigation with Pfizer Inc related to Viagra, paving the way for the launch of the drug’s generic version in the United States once approved. Mylan said on Monday that the settlement would allow it to…
Lesen Sie weiter